Retinopathy of prematurity.
This article briefly reviews the history of ROP followed by a discussion of the pathogenesis of this complex disorder. We describe the International Classification System for ROP and identify risk factors and screening recommendations. Finally, we discuss some of the measures that have been used in an attempt to both prevent and treat ROP.
Askin
Debbie Fraser
DF
Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba R3T 2N2, Canada. debbie_fraser@umanitoba.ca
Diehl-Jones
William
W
D017679:Cryotherapy; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D015931:Intensive Care, Neonatal / Q000379:methods*; D017075:Laser Coagulation; D017283:Neonatal Nursing / Q000379:methods*; D015997:Neonatal Screening; D018529:Nutritional Support; D010102:Oxygen Inhalation Therapy / Q000009:adverse effects / Q000379:methods / Q000451:nursing; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012163:Retinal Detachment / Q000209:etiology; D012178:Retinopathy of Prematurity / Q000145:classification / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control*; D012307:Risk Factors; D012720:Severity of Illness Index; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
D042461:Vascular Endothelial Growth Factor A; D007334:Insulin-Like Growth Factor I